Regenerex Pharma (RGPX) Assets Average (2011 - 2025)

Regenerex Pharma (RGPX) has 13 years of Assets Average data on file, last reported at $690568.5 in Q3 2025.

• Assets Average for Q3 2025 came in at $690568.5, up 1.4% year-over-year; the trailing twelve-month figure through Sep 2025 was $690568.5 (up 1.4% YoY), and the FY2025 annual result was $1.0 million, up 162.53% from the prior year.
• Assets Average fell to $690568.5 in Q3 2025 per RGPX's latest filing, from $1.0 million in the prior quarter.
• Over five years, Assets Average peaked at $1.0 million in Q2 2025 and troughed at $8234.0 in Q1 2023.
• A 5-year average of $429357.3 and a median of $523071.5 in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2021 and 2023: Assets Average plunged 95.81% in 2021, then soared 10125.26% in 2023.
• A 5-year view of Assets Average shows it stood at $11718.5 in 2021, then declined by 20.25% to $9345.0 in 2022, then surged by 9449.42% to $892393.0 in 2023, then fell by 28.29% to $639907.0 in 2024, then increased by 7.92% to $690568.5 in 2025.
• Business Quant data shows RGPX's Assets Average at $690568.5 in Q3 2025, $1.0 million in Q2 2025, and $955048.0 in Q1 2025.